je.st
news
GSK readies 'bubble boy' drug as big pharma bets on gene therapy
2015-04-27 19:30:48| Biotech - Topix.net
GlaxoSmithKline is close to seeking European approval for a gene therapy drug to fight adenosine deaminase severe combined immune deficiency in the latest sign of a renaissance in the technology to fix faulty genes. A uniQure bioprocessing engineer checks a monitor of a sterile disposable plastic cell culture bag as it is placed onto a rocking platform in a laboratory at Dutch biotech company uniQure in Amsterdam December 13, 2012.
Tags: big
boy
drug
therapy
Category:Biotechnology and Pharmaceuticals